Young-onset type 2 diabetes mellitus - implications for morbidity and mortality.,Nature Reviews Endocrinology

当前位置： X-MOL 学术 › Nat. Rev. Endocrinol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Young-onset type 2 diabetes mellitus - implications for morbidity and mortality.
Nature Reviews Endocrinology ( IF 40.5 ) Pub Date : 2020-03-20 , DOI: 10.1038/s41574-020-0334-z
Dianna J Magliano _{1,

2} , Julian W Sacre ₁ , Jessica L Harding ₃ , Edward W Gregg ₄ , Paul Z Zimmet ₅ , Jonathan E Shaw _{1,

2}

Affiliation

Accumulating data suggest that type 2 diabetes mellitus (T2DM) in younger people (aged <40 years), referred to as young-onset T2DM, has a more rapid deterioration of β-cell function than is seen in later-onset T2DM. Furthermore, individuals with young-onset T2DM seem to have a higher risk of complications than those with type 1 diabetes mellitus. As the number of younger adults with T2DM increases, young-onset T2DM is predicted to become a more frequent feature of the broader diabetes mellitus population in both developing and developed nations, particularly in certain ethnicities. However, the magnitude of excess risk of premature death and incident complications remains incompletely understood; likewise, the potential reasons for this excess risk are unclear. Here, we review the evidence pertaining to young-onset T2DM and its current and future burden of disease in terms of incidence and prevalence in both developed and developing nations. In addition, we highlight the associations of young-onset T2DM with premature mortality and morbidity.

更新日期：2020-03-20

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>